Revumenib (Revuforj) costs ~$39,500/month. Learn about copay programs, patient assistance, and other ways to reduce your out-of-pocket costs in 2026.
Let's start with the number that probably brought you here: Revumenib (brand name Revuforj) has a wholesale acquisition cost of approximately $39,500 per month. That's roughly $474,000 per year.
For a medication you need to treat relapsed or refractory acute leukemia, that number can feel paralyzing. But here's the good news: most patients don't pay anywhere near that amount. Between manufacturer programs, insurance coverage, and patient assistance, there are real ways to bring your out-of-pocket costs down significantly — in some cases, to $0.
In this guide, we'll walk through every option available to help you save money on Revumenib in 2026.
Without insurance, the cost of Revumenib is staggering:
There is no generic version of Revumenib available, and none is expected in the near term. The drug was only approved in November 2024, and patent protections will prevent generic competition for years.
Because Revumenib is only available through specialty pharmacies, traditional discount cards from services like GoodRx or SingleCare typically do not apply to this medication. The savings options for specialty oncology drugs work differently than for common medications.
The single most important savings program for Revumenib patients is the Revuforj Copay Program, offered through Syndax Pharmaceuticals' patient support program called SyndAccess.
If you have commercial insurance, this program should be your first stop. It can eliminate your copay entirely.
For patients who don't qualify for the copay program — including those without insurance or on government programs — SyndAccess offers additional financial assistance.
The SyndAccess program provides:
Contact SyndAccess at 1-888-567-SYND (7963) to discuss your specific situation. Even if you're not sure whether you qualify for any programs, the SyndAccess team can evaluate your options.
Most commercial insurance plans and government programs (Medicare, Medicaid) do cover Revumenib, but typically require:
Several non-profit organizations offer financial assistance to cancer patients, including help with medication costs, travel, and living expenses during treatment:
These organizations may have specific programs for patients with acute leukemia or for expensive oncology medications. Availability and eligibility vary, so check directly with each organization.
If you're being treated at a hospital or cancer center, ask about their financial assistance or charity care programs. Many hospitals, especially academic medical centers and non-profit institutions, have programs to help patients cover the cost of expensive medications.
Some states offer additional pharmaceutical assistance programs for residents who need help paying for prescription medications. Check with your state's health department or insurance commission to see what's available in your area.
If you're on Medicare, the Revuforj Copay Program does not apply to you. However, Medicare Part D does typically cover specialty medications like Revumenib, though you may face significant out-of-pocket costs in the coverage gap ("donut hole").
Options for Medicare patients include:
Unlike common medications that you can find discounted on services like GoodRx, SingleCare, or RxSaver, Revumenib is a specialty oncology drug that is not typically listed on consumer discount card platforms. Its distribution through specialty pharmacies means the pricing and discount structures work differently.
The manufacturer's own copay program through SyndAccess is the primary mechanism for reducing out-of-pocket costs for commercially insured patients. Don't waste time searching for coupons on third-party sites — go directly to SyndAccess.
Revumenib's price tag is intimidating, but don't let it stop you from getting the treatment you need. The combination of the Revuforj Copay Program (potentially $0 for commercially insured patients), SyndAccess patient assistance, non-profit support organizations, and insurance coverage means that most patients can access Revumenib at a cost they can manage.
The key is to start early and use all the resources available to you:
Use Medfinder to find where Revumenib is available near you, and check out our other guides for more information:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
